Estrogen sulfotransferase (SULT1E1) expression in benign and malignant human bone tumors

Journal of Surgical Oncology

Volumn 95, Issue 7, 2007, Pages 572-581

  Svoboda, Martin ^a   Thalhammer, Theresia ^a   Aust, Sylvia ^a   Arrich, Ferdi ^a   Assadian, Ojan ^a,b   Toma, Cyril D ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Prince Court Medical Centre ^*  (Malaysia)

Author keywords

Bone tumor; Estrogen; Estrogen receptor alpha (ER ); Estrogen sulfotransferase; SULT1E1

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN SULFOTRANSFERASE; MESSENGER RNA; ESTRADIOL; ESTRONE SULFOTRANSFERASE; SULFOTRANSFERASE; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ARTICLE; BONE TUMOR; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; EWING SARCOMA; GENDER; HUMAN; HUMAN CELL; HUMAN TISSUE; LEIOMYOSARCOMA; METASTASIS; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR LOCALIZATION; ADOLESCENT; ADULT; AGED; BONE MARROW; CHILD; FEMALE; MALE; METABOLISM; MIDDLE AGED; OSTEOBLAST; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ADOLESCENT; ADULT; AGED; BONE MARROW; BONE NEOPLASMS; CELL LINE, TUMOR; CHILD; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOBLASTS; OSTEOSARCOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SARCOMA, EWING'S; SULFOTRANSFERASES;

EID: 34347376576     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20748     Document Type: Article

References (39)

1. O'Dowd A: Research identifies the most common cancers in teenagers and young adults. BMJ 2006;332:814.
2. Turcotte RE: Giant cell tumor of bone. Orthop Clin North Am 2006;37:35-51.
3. Bertoni F, Bacchini P, Staals EL: Malignancy in giant cell tumor of bone. Cancer 2003;97:2520-2529.
4. Zehetgruber H, Bittner B, Gruber D, et al.: Prevalence of aneurysmal and solitary bone cysts in young patients. Clin Orthop Relat Res 2005;439:136-143.
5. Betsy M, Kupersmith LM, Springfield DS: Metaphyseal fibrous defects. J Am Acad Orthop Surg 2004;12:89-95.
6. van Giffen NH, van Rhijn LW, van Ooij A, et al.: Benign fibrous histiocytoma of the posterior arch of C1 in a 6-year-old boy: A case report. Spine 2003;28:E359-E363.
7. Herzog CE: Overview of sarcomas in the adolescent and young adult population. J Pediatr Hematol Oncol 2005;27:215-218.
8. Hahn M, Dormans JP: Primary bone malignancies in children. Curr Opin Pediatr 1996;8:71-74.
9. Craft AW: Challenges in the management of bone tumors - 1996. Ann NY Acad Sci 1997;824:167-179.
10. Mundy GR: Mechanisms of bone metastasis. Cancer 1997;80: 1546-1556.
11. Lipton A: Pathophysiology of bone metastases: How this knowledge may lead to therapeutic intervention. J Support Oncol 2004;2:205-213; discussion 213-204, 216-207, 219-220.
12. Grumbach MM: Estrogen, bone, growth and sex: A sea change in conventional wisdom. J Pediatr Endocrinol Metab 2000;13: 1439-1455.
13. Syed F, Khosla S: Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun 2005;328:688-696.
14. Lindberg MK, Erlandsson M, Alatalo SL, et al.: Estrogen receptor alpha, but not estrogen receptor beta, is involved in the regulation of the OPG/RANKL (osteoprotegerin/receptor activator of NF-kappa B ligand) ratio and serum interleukin-6 in male mice. J Endocrinol 2001;171:425-433.
15. Elkin M, Orgel A, Kleinman HK: An angiogenic switch in breast cancer involves estrogen and soluble vascular endothelial growth factor receptor 1. J Natl Cancer Inst 2004;96:875-878.
16. Cleton-Jansen AM, van Beerendonk HM, Baelde HJ, et al.: Estrogen signaling is active in cartilaginous tumors: Implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma. Clin Cancer Res 2005;11:8028-8035.
17. Saito H, Yanaihara T: Steroid formation in osteoblast-like cells. J Int Med Res 1998;26:1-12.
18. Muir M, Romalo G, Wolf L, et al.: Estrone sulfate is a major source of local estrogen formation in human bone. J Clin Endocrinol Metab 2004;89:4685-4692.
19. Falany JL, Macrina N, Falany CN: Regulation of MCF-7 breast cancer cell growth by beta-estradiol sulfation. Breast Cancer Res Treat 2002;74:167-176.
20. Sasano H, Suzuki T, Nakata T, et al.: New development in intracrinology of breast carcinoma. Breast Cancer 2006;13:129-136.
21. Purohit A, Flanagan AM, Reed MJ: Estrogen synthesis by osteoblast cell lines. Endocrinology 1992;131:2027-2029.
22. Raeside JI, Christie HL, Forster L, et al.: Estradiol-17beta sulfotransferase activity in canine osteosarcoma D17 cells. Biochem Biophys Res Commun 2000;273:505-508.
23. Jonsson KB, Frost A, Nilsson O, et al.: Three isolation techniques for primary culture of human osteoblast-like cells: A comparison. Acta Orthop Scand 1999;70:365-373.
24. Voegele TJ, Voegele-Kadletz M, Esposito V, et al.: The effect of different isolation techniques on human osteoblast-like cell growth. Anticancer Res 2000;20:3575-3581.
25. Bertram H, Mayer H, Schliephake H: Effect of donor characteristics, technique of harvesting and in vitro processing on culturing of human marrow stroma cells for tissue engineered growth of bone. Clin Oral Implants Res 2005;16:524-531.
26. Aust S, Obrist P, Klimpfinger M, et al.: Altered expression of the hormone- and xenobiotic-metabolizing sulfotransferase enzymes 1A2 and 1C1 in malignant breast tissue. Int J Oncol 2005;26: 1079-1085.
27. Enneking WF: A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res 1986;204:9-24.
28. Eselgrim M, Grunert H, Kuhne T, et al.: Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials. Pediatr Blood Cancer 2006;47:42-50.
29. Juergens C, Weston C, Lewis I, et al.: Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial. Pediatr Blood Cancer 2006;47: 22-29.
30. Monroe DG, Getz BJ, Johnsen SA, et al.: Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta. J Cell Biochem 2003;90:315-326.
31. Meunier V, Bourrie M, Julian B, et al.: Expression and induction of CYP1A1/1A2, CYP2A6 and CYP3A4 in primary cultures of human hepatocytes: A 10-year follow-up. Xenobiotica 2000;30: 589-607.
32. Runge-Morris M, Kocarek TA: Regulation of sulfotransferases by xenobiotic receptors. Curr Drug Metab 2005;6:299-307.
33. Nakamura Y, Miki Y, Suzuki T, et al: Steroid sulfatase and estrogen sulfotransferase in the atherosclerotic human aorta. Am J Pathol 2003;163:1329-1339.
34. Fohr B, Schulz A, Battmann A: Sex steroids and bone metabolism: Comparison of in vitro effects of 17beta-estradiol and testosterone on human osteosarcoma cell lines of various gender and differentiation. Exp Clin Endocrinol Diabetes 2000;108:414-423.
35. Bovee JV, Cleton-Jansen AM, Taminiau AH, et al.: Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. Lancet Oncol 2005;6:599-607.
36. Fox SB, Leek RD, Bliss J, et al.: Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients. J Natl Cancer Inst 1997;89:1044-1049.
37. Reddi AH, Roodman D, Freeman C, et al.: Mechanisms of tumor metastasis to the bone: Challenges and opportunities. J Bone Miner Res 2003;18:190-194.
38. Simpson ER: Sources of estrogen and their importance. J Steroid Biochem Mol Biol 2003;86:225-230.
39. Tamura HO, Taniguchi K, Hayashi E, et al.: Expression profiling of sulfotransferases in human cell lines derived from extra-hepatic tissues. Biol Pharm Bull 2001;24:1258-1262.